Minnesota SF 131: Drug manufacturers requirement to report and maintain prescription drug prices authorization; prescription drug formularies filing requirement; health carriers denying or limiting coverage due to lack of prior authorization prohibition; prescription benefit tool requirements establishment; prescription drug benefit transparency and disclosure requirement

Status: Author added Nelson (as of 2022-03-28)

State: Minnesota · Session: 2021-2022 · Bill: SF 131

Subjects: Drugs and Medicine, Health and Health Department, Human Services and Human Services Department

Sponsors: Draheim, Nelson, Putnam

View Minnesota SF 131 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.